Skip to main content
. 2010 Apr 21;95(6):2746–2754. doi: 10.1210/jc.2009-0919

Table 2.

(CAG)n and hormone concentrations by third wave (T3) frailty status

Not frail (n = 251)
Intermediate (n = 286)
Frail (n = 46)
P value
Mean sd Mean sd Mean sd
(CAG)n 22.1 (2.97) 22.1 (3.09) 22.3 (2.58) 0.897
T1
 Testosterone (ng/dL) 534.7 (167.80) 512.2 (168.12) 523.1 (187.57) 0.312
 FT (ng/dl) 13.6 (5.04) 13.3 (4.97) 12.7 (5.79) 0.437
 SHBG (nm) 32.6 (16.79) 31.5 (16.79) 34.3 (15.11) 0.489
 LH 4.7 (2.90) 4.7 (2.81) 4.9 (2.97) 0.951
T2
 Testosterone (ng/dl) 472.1 (154.96) 442.5 (156.35) 442.1 (165.66) 0.078
 FT (ng/dl) 11.2 (3.75) 10.4 (3.63) 9.0 (3.37) <0.001
 SHBG (nm) 34.2 (16.10) 33.7 (15.44) 42.6 (22.67) 0.002
 LH 5.5 (3.60) 5.8 (5.10) 6.2 (4.95) 0.511
T3
 Testosterone (ng/dl) 438.6 (163.92) 406.1 (157.52) 410.7 (186.19) 0.081
 FT (ng/dl) 7.6 (2.76) 7.0 (2.78) 5.8 (2.44) <0.001
 SHBG (nm) 50.8 (19.86) 50.7 (19.76) 63.5 (22.70) <0.001
 LH 4.2 (3.96) 4.7 (4.72) 5.6 (3.86) 0.151
Rate of change, T1 to T3
 Testosterone (ng/dl · yr) −6.4 (11.58) −7.2 (12.42) −6.7 (12.76) 0.738
 FT (ng/dl/yr) −0.4 (0.31) −0.4 (0.37) −0.4 (0.33) 0.643
 SHBG (nm/yr) 1.2 (1.25) 1.3 (1.38) 2.0 (1.46) 0.003
 LH −0.0 (0.24) 0.0 (0.25) 0.0 (0.20) 0.063
HHS Vulnerability Disclosure